{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:18:25Z","timestamp":1772659105144,"version":"3.50.1"},"reference-count":12,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2026,3]]},"DOI":"10.2967\/jnmt.125.271414","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:10:12Z","timestamp":1768320612000},"page":"55-58","source":"Crossref","is-referenced-by-count":0,"title":["Real-Time Imaging of\n                    <sup>177<\/sup>\n                    Lu-Labeled Radiopharmaceutical Infusions with a Portable \u03b3-Camera: Pilot Trial Results"],"prefix":"10.2967","volume":"54","author":[{"given":"Jorge D.","family":"Oldan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Khandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Ivanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"2026030412502824000_54.1.55.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.03.004"},{"key":"2026030412502824000_54.1.55.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026030412502824000_54.1.55.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2026030412502824000_54.1.55.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267208"},{"key":"2026030412502824000_54.1.55.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267955"},{"key":"2026030412502824000_54.1.55.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.119.228098"},{"key":"2026030412502824000_54.1.55.7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmir.2020.01.003","article-title":"Topical sensor for the assessment of injection quality for 18F-FDG, 68Ga-PSMA and 68Ga-DOTATATE positron emission tomography","volume":"51","author":"Sanchez","year":"2020","journal-title":"J Med Imaging Radiat Sci."},{"key":"2026030412502824000_54.1.55.8","doi-asserted-by":"crossref","first-page":"1126029","DOI":"10.3389\/fnume.2023.1126029","article-title":"Active monitoring improves radiopharmaceutical administration quality","volume":"3","author":"Crowley","year":"2023","journal-title":"Front Nucl Med."},{"key":"2026030412502824000_54.1.55.9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S1470-2045(25)00189-5","article-title":"Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial","volume":"26","author":"Fizazi","year":"2025","journal-title":"Lancet Oncol."},{"key":"2026030412502824000_54.1.55.10","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","article-title":"[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study","volume":"403","author":"Singh","year":"2024","journal-title":"Lancet."},{"key":"2026030412502824000_54.1.55.11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40658-022-00488-6","article-title":"Development of a classifier for [18F]fluorodeoxyglucose extravasation severity using semi-quantitative readings from topically applied detectors","volume":"9","author":"Perrin","year":"2022","journal-title":"EJNMMI Phys."},{"key":"2026030412502824000_54.1.55.12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12880-020-0408-3","article-title":"Assessing and reducing PET radiotracer infiltration rates: a single center experience in injection quality monitoring methods and quality improvement","volume":"20","author":"Osborne","year":"2020","journal-title":"BMC Med Imaging."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.125.271414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:50:35Z","timestamp":1772657435000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.125.271414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,4]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.2967\/jnmt.125.271414"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.125.271414","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}